News

MIG, pursuant to the manufacturing agreement with Revolutions Medical, has guaranteed the production and delivery of a minimum of five million 3cc safety syringes per month for a

In his role, Ray is expected to lead business development efforts aimed at expanding the company’s pipeline of differentiated protein therapeutics. Prior to joining Itero, Ray was the

Pronova BioPharma’s first commercialized product is branded as Omacor in a number of countries throughout Europe and Asia and as Lovaza in the US. Pronova BioPharma CEO Morten

Novartis has licensed INC424 from Incyte for development and commercialisation outside the US, while the rights for the development and commercialisation of INC424 in the US are retained

NuGEN Technologies is the provider of RNA and DNA amplification and sample preparation technologies for genomic analysis. Initiated in 1948, the Framingham Heart Study is an epidemiological study,

Prior to joining Ensemble, Hibben has worked as the chief business officer of Cequent Pharmaceuticals. Before Cequent, Hibben was the vice president of Business Development and Alliance Management

BioScale said that the ViBE Workstation is a new productivity tool capable of performing several important BioProcess applications including Host Cell Protein assays, Protein A residual contaminant and

Out of the five recently introduced products, three are prescription drugs and the remaining two are non-prescription or over-the-counter (OTC) medicines. The new products are intended to supplement,

Polydex Pharma said that the decrease in sales is primarily due to a reduction in orders received from a few larger customers that had experienced a slow-down in